Published in Chem Res Toxicol on June 01, 2001
The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect (2002) 2.48
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect (2010) 2.16
Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect (2007) 1.77
Folic acid supplementation lowers blood arsenic. Am J Clin Nutr (2007) 1.70
Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci (2008) 1.54
Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol Appl Pharmacol (2005) 1.52
Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect (2006) 1.51
Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect (2008) 1.45
Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol (2007) 1.41
Monomethylarsonous acid induces transformation of human bladder cells. Toxicol Appl Pharmacol (2006) 1.38
Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1. Biochem J (2004) 1.30
Arsenic toxicity: the effects on plant metabolism. Front Physiol (2012) 1.29
Arsenic binding to proteins. Chem Rev (2013) 1.28
Arsenic immunotoxicity: a review. Environ Health (2013) 1.27
Earth Abides Arsenic Biotransformations. Annu Rev Earth Planet Sci (2014) 1.15
Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure. Toxicol Appl Pharmacol (2009) 1.12
Oxidation State Specific Generation of Arsines from Methylated Arsenicals Based on L- Cysteine Treatment in Buffered Media for Speciation Analysis by Hydride Generation - Automated Cryotrapping - Gas Chromatography-Atomic Absorption Spectrometry with the Multiatomizer. Spectrochim Acta Part B At Spectrosc (2008) 1.11
Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration. Toxicol Appl Pharmacol (2005) 1.09
Methylarsonous acid transport by aquaglyceroporins. Environ Health Perspect (2006) 1.08
A C⋅As lyase for degradation of environmental organoarsenical herbicides and animal husbandry growth promoters. Proc Natl Acad Sci U S A (2014) 1.06
Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ Health Perspect (2004) 1.06
Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity. Environ Health Perspect (2010) 1.03
Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water. Environ Health Perspect (2008) 1.03
Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci (2010) 1.01
Arsenic-based antineoplastic drugs and their mechanisms of action. Met Based Drugs (2008) 1.00
Respiratory cancer and inhaled inorganic arsenic in copper smelters workers: a linear relationship with cumulative exposure that increases with concentration. Environ Health Perspect (2008) 0.99
Comparative functional genomic analysis identifies distinct and overlapping sets of genes required for resistance to monomethylarsonous acid (MMAIII) and arsenite (AsIII) in yeast. Toxicol Sci (2009) 0.97
Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity. J Toxicol (2012) 0.95
Associations of plasma selenium with arsenic and genomic methylation of leukocyte DNA in Bangladesh. Environ Health Perspect (2011) 0.94
Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicol Appl Pharmacol (2011) 0.89
Mathematical model insights into arsenic detoxification. Theor Biol Med Model (2011) 0.89
The importance of stereochemically active lone pairs for influencing Pb(II) and As(III) protein binding. Chemistry (2012) 0.87
Association between arsenic suppression of adipogenesis and induction of CHOP10 via the endoplasmic reticulum stress response. Environ Health Perspect (2012) 0.86
Deficiency in the nuclear factor E2-related factor 2 renders pancreatic β-cells vulnerable to arsenic-induced cell damage. Toxicol Appl Pharmacol (2012) 0.85
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants. Int J Mol Sci (2015) 0.84
Interaction of plasma glutathione redox and folate deficiency on arsenic methylation capacity in Bangladeshi adults. Free Radic Biol Med (2014) 0.83
A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh. J Occup Environ Med (2014) 0.82
Monomethylated trivalent arsenic species disrupt steroid receptor interactions with their DNA response elements at non-cytotoxic cellular concentrations. J Appl Toxicol (2013) 0.82
Inhibition by methylated organo-arsenicals of the respiratory 2-oxo-acid dehydrogenases. J Organomet Chem (2009) 0.81
Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite. Hum Exp Toxicol (2009) 0.81
Monomethylarsonous acid inhibited endogenous cholesterol biosynthesis in human skin fibroblasts. Toxicol Appl Pharmacol (2014) 0.80
Arsenite elicits anomalous sulfur starvation responses in barley. Plant Physiol (2013) 0.78
Methylated trivalent arsenic-glutathione complexes are more stable than their arsenite analog. Bioinorg Chem Appl (2008) 0.77
A transgenic Drosophila model for arsenic methylation suggests a metabolic rationale for differential dose-dependent toxicity endpoints. Toxicol Sci (2011) 0.77
The NIEHS Superfund Research Program: 25 Years of Translational Research for Public Health. Environ Health Perspect (2015) 0.76
Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget (2017) 0.75
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links? Curr Diab Rep (2017) 0.75
Differential sensitivities of bone marrow, spleen and thymus to genotoxicity induced by environmentally relevant concentrations of arsenite. Toxicol Lett (2016) 0.75
Genetic k-means clustering approach for mapping human vulnerability to chemical hazards in the industrialized city: a case study of Shanghai, China. Int J Environ Res Public Health (2013) 0.75
Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect (1999) 3.07
DMSA and DMPS--water soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol (1983) 1.76
Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol (2001) 1.65
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58
Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. J Pediatr (1994) 1.58
Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB J (1991) 1.27
Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem Res Toxicol (1995) 1.26
Rabbit muscle creatine phosphokinase. CDNA cloning, primary structure and detection of human homologues. J Biol Chem (1984) 1.24
2,2',3,3',6,6'-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P450 2B1 and 2B11. Chem Res Toxicol (1999) 1.23
The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci (1999) 1.16
Farnesyl pyrophosphate synthetase. Mechanistic studies of the 1'-4 coupling reaction with 2-fluorogeranyl pyrophosphate. J Biol Chem (1978) 1.11
Neurobehavioral effects from exposure to dental amalgam Hg(o): new distinctions between recent exposure and Hg body burden. FASEB J (1998) 1.10
NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules. Pflugers Arch (2000) 1.09
N-(2,3-dimercaptopropyl)phthalamidic acid (DMPA) increases polonium-210 excretion. Biol Met (1990) 1.07
A deoxyribonuclease found after infection of Bacillus subtilis with phage SP3. Proc Natl Acad Sci U S A (1965) 1.04
Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem Res Toxicol (1999) 1.04
DNA and gene therapy: uncoating of polyoma pseudovirus in mouse embryo cells. Proc Natl Acad Sci U S A (1970) 1.04
Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture. Toxicol Appl Pharmacol (2006) 1.03
Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic. Toxicol Appl Pharmacol (1996) 1.02
DNA and gene therapy: transfer of mouse DNA to human and mouse embryonic cells by polyoma pseudovirions. Proc Natl Acad Sci U S A (1971) 1.02
Formation of nucleoprotein complexes between polyoma empty capsides and DNA. J Virol (1975) 1.01
Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. J Pharmacol Exp Ther (1994) 0.98
Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. J Pharmacol Exp Ther (1991) 0.97
Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxicol (2000) 0.97
Central nervous system toxicity of manganese. I. Inhibition of spontaneous motor activity in rats after intrathecal administration of manganese chloride. Fundam Appl Toxicol (1995) 0.96
Structural basis of the antagonism between inorganic mercury and selenium in mammals. Chem Res Toxicol (2000) 0.96
The deoxycytidylate deaminase found in Bacillus subtilis infected with phage SP8. Biochemistry (1967) 0.95
Central nervous system toxicity of manganese. II: Cocaine or reserpine inhibit manganese concentration in the rat brain. Neurotoxicology (1999) 0.95
Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol Appl Pharmacol (1999) 0.95
A cytochrome P450 terpenoid hydroxylase linked to the suppression of insect juvenile hormone synthesis. Proc Natl Acad Sci U S A (1998) 0.94
Deoxythymidylate 5'-nucleotidase. Purification and properties of an enzyme found after infection of Bacillus subtilis with phage SP5C. J Biol Chem (1966) 0.94
Polyoma pseudovirions. I. Sequence of events in primary mouse embryo cells leading to pseudovirus production. J Virol (1972) 0.93
Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol Appl Pharmacol (1999) 0.92
Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat. J Pharmacol Exp Ther (1993) 0.91
Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology (1994) 0.91
Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation. J Pharmacol Exp Ther (1990) 0.91
Behavioral effects of low-level exposure to Hg0 among dental professionals: a cross-study evaluation of psychomotor effects. Neurotoxicol Teratol (1998) 0.89
Fluorometric determination of 2,3-dimercaptopropane-1-sulfonic acid and other dithiols by precolumn derivatization with bromobimane and column liquid chromatography. J Chromatogr (1986) 0.88
DMSA, DMPS, and DMPA--as arsenic antidotes. Fundam Appl Toxicol (1984) 0.87
Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid. Toxicol Appl Pharmacol (1989) 0.87
Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem Res Toxicol (2000) 0.86
Cell-free assembly of a polyoma-like particle from empty capsids and DNA. Virology (1979) 0.86
Protection of mice against the lethal effects of sodium arsenite by 2,3 dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid. Biochem Biophys Res Commun (1980) 0.86
Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein. Fundam Appl Toxicol (1990) 0.85
Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides. J Pharmacol Exp Ther (1996) 0.85
Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. J Pharmacol Exp Ther (1996) 0.83
Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro. Toxicol Appl Pharmacol (1998) 0.83
Polyoma pseudovirions. II. Influence of host cell on pseudovirus production. J Virol (1973) 0.83
Diversity of inorganic arsenite biotransformation. Biol Trace Elem Res (1999) 0.83
Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutat Res (1997) 0.83
The use of DNA for gene therapy--the need, experimental approach, and implications. Perspect Biol Med (1970) 0.83
DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther (1998) 0.83
Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine. Anal Biochem (1987) 0.82
Polyoma-like particle: characterization of the DNA encapsidated in vitro by polyoma empty capsids. J Biol Chem (1982) 0.81
Letter: Prenyltransferase. New evidence for an ionization-condensation-elimination mechanism with 2-fluorogeranyl pyrophosphate. J Am Chem Soc (1977) 0.81
Protection of mice against lethal effects of sodium arsenite--a quantitative comparison of a number of chelating agents. Toxicol Appl Pharmacol (1981) 0.81
Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acid. Adv Enzyme Regul (1982) 0.81
Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine. Toxicol Appl Pharmacol (1989) 0.81
Evaluation of Drosophila melanogaster as an alternative animal for studying the neurotoxicity of heavy metals. Biometals (1992) 0.80
The synthesis and breakdown of nucleic acids in mammalian cells transformed by oncogenic viruses. I. Purification and properties of an endonuclease from baby hamster kidney cells transformed by polyoma virus. J Biol Chem (1970) 0.80
Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rat. Toxicology (1996) 0.79
Sequential cleavage of dinucleotides from DNA by phage Sp3 DNAse. Proc Natl Acad Sci U S A (1968) 0.79
The polyoma pseudovirion--its properties, production, and use in transferring DNA to mouse and human cells. Johns Hopkins Med J Suppl (1973) 0.79
BAL increases the arsenic-74 content of rabbit brain. Toxicol Appl Pharmacol (1983) 0.78
Degradation of pseudoviral DNA after infection of mouse cells with polyoma pseudovirions. Proc Natl Acad Sci U S A (1974) 0.78
Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid. Life Sci (1982) 0.78
Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid. Biochem Pharmacol (1989) 0.77
Utilization of renal slices to evaluate the efficacy of chelating agents for removing mercury from the kidney. Toxicology (1997) 0.77
Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems. Drug Metab Dispos (2001) 0.77
N-(2,3-dimercaptopropyl)phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication. Toxicol Appl Pharmacol (1984) 0.77
Lead chelates of meso- and racemic-dimercaptosuccinic acid. J Inorg Biochem (1989) 0.76
Gene therapy systems: the need, experimental approach, and implications. Ann N Y Acad Sci (1971) 0.76
Synthesis and properties of the monomethyl ester of meso-dimercaptosuccinic acid and its chelates of lead (II), cadmium(II), and mercury(II). Chem Res Toxicol (1991) 0.76
Penicillamine and analogous chelating agents. Ann N Y Acad Sci (1971) 0.76
Experimental gene delivery systems for mammalian cells-the polyoma pseudovirus system. Adv Enzyme Regul (1978) 0.75
DL- and meso-dimercaptosuccinic acid: in vitro and in vivo studies with sodium arsenite. Toxicol Appl Pharmacol (1983) 0.75
Water soluble dithiol metal binding agents--efficacies and biotransformation. Acta Pharmacol Toxicol (Copenh) (1986) 0.75
Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite. J Pharmacol Exp Ther (1983) 0.75
The dimethyl ester of meso-2,3-dimercaptosuccinic acid and its interactions with Cd2+ and rabbit liver metallothionein I. Chem Res Toxicol (1992) 0.75
Sequential cleavage of dinucleotides from DNA by SP3 DNase. 3. Substrate specificity and initiation of the hydrolysis from the 5-terminus of polynucleotides. J Mol Biol (1970) 0.75
Use of duodenal drainage in the diagnosis of acalculous gallbladder disease. Am Surg (1976) 0.75
Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit. Drug Metab Dispos (1988) 0.75
Gene transfer by polyoma-like particles assembled in a cell-free system. Science (1983) 0.75
Isolation and characterization of a green tissue-specific promoter from pigeonpea [Cajanus cajan (L.) Millsp.]. Indian J Exp Biol (2005) 0.75
Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit. Toxicol Appl Pharmacol (1985) 0.75
Polyoma pseudovirions: an experimental model for the development of DNA for gene therapy. Fed Proc (1972) 0.75
A modification of the Dukes' classification of carcinoma of the colon and rectum. Am Surg (1978) 0.75
Selective inactivation by 21-chlorinated steroids of rabbit liver and adrenal microsomal cytochromes P-450 involved in progesterone hydroxylation. Arch Biochem Biophys (1988) 0.75
Selective inactivation of rat liver cytochromes P-450 by 21-chlorinated steroids. Drug Metab Dispos (1989) 0.75
Assembly of a polyoma-like particle from empty capsids and DNA in a cell-free system. Adv Enzyme Regul (1980) 0.75